LSTA
Lisata Therapeutics·NASDAQ
--
--(--)
--
--(--)
3.88 / 10
Netural
Fund flow scores 7.75 (good), with strong large‑cap inflows despite overall negative trend. Analyst coverage is limited to one neutral rating with zero historical win rate, and market expectations are pessimistic. Positive money flow is offset by weak analyst sentiment.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
0%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-21
InstitutionBrookline Capital
Times predicted2
Historical Win Rate0.0%
What is the market sentiment for LSTA?
- LSTA holds a Bearish analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 3.88/10 (Netural).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
